What You Should Know:
– Strategic acquisition of leading patient adherence technology and services provider to complement CareMetx current suite of patient access products.
CareMetx, LLC, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today the acquisition of Human Care Systems, Inc. (HCS), a company focused on helping patients adhere to and benefit from pharmaceutical and biotechnology products. Details of the acquisition were not disclosed.
Specialty Medications Deserve Patient Solutions
Founded in 2008, Human Care Systems (HCS) delivers improved access, use, experience, and outcomes from medicines by helping patients better manage complex diseases and therapies. Its flagship offering is Resilix®, a proprietary technology platform that delivers a personalized treatment experience for patients. This acquisition will enable CareMetx to support the entire patient journey- from initiation to adherence- by adding services that address treatment barriers for specialty therapies.
“This acquisition marks the beginning of a very exciting time for CareMetx and HCS,” said Mark Hansan, CareMetx President and Chief Executive Officer. “Our combined organization and team members share a passion for supporting a patient’s journey to access and adhere to specialty therapies.”
